TRION Research GmbH


    • Company type:
      • Manufacturer
    • Year founded:
    • not available
    • Employees (at the site):
    • 14
    • Turnover range:
    • <5m EUR
    • Products/services:
    • TRION Research offers dedicated preclinical and clinical support, with a particular focus on immunomonitoring services, tumor biology analyses and antibody conjugation and supply.
      Drug Development, Antibody Production Service, Immune Therapy

    • Core competencies:
    • Trion Research develops a new class of intact trifunctional antibodies (triomab®) which are specifically targeted at characteristic antigens of tumours, such as B-cell-lymphoma and malignant melanoma. The advantage of these trifunctional antibodies over conventional therapeutic approaches is the fact that they simultaneously activate two immunological cascades and are thus particularly effective in destroying tumour cells. Trion Research is further active in the development of pharmaceutical diagnostics, focussing on pharmacodynamic and pharmacokinetic analyses in immunotherapeutic clinical studies.

    • Language skills:
    • English
    • Key Tech / section:
      • Biotechnology: Molecular diagnostics for humans
      • Biotechnology: Technical services for biotechnology
    • Industries NACE:
      • 72.19: Other research and experimental development on natural sciences and engineering
      • 32.99: Other manufacturing n.e.c.
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Horst Lindhofer (Mr.)
      - Management